The Global Cannabis Terminal.
Yours in 8 seconds.
Follow international cannabis securities, published market briefs and company research. Explore the available tools, then choose the reporting and account features that suit your research.
| Date | Catalyst | Impact |
|---|---|---|
| Jul 02 | DEA · Final rescheduling rule comment window closes | ●●●●● |
| Jul 09 | SAFER · Senate Banking markup (tentative) | ●●●●○ |
| Jul 15 | VFF · Q2 earnings (pre-market) | ●●●○○ |
| Jul 22 | TLRY · Q4 earnings (after close) | ●●●●○ |
| Jul 28 | GTBIF · Q2 earnings + analyst day | ●●●●● |
The Global Cannabis Terminal.
Yours in 8 seconds.
Every trading day, the only newsroom built exclusively for cannabis capital markets ships you institutional-grade briefs, AI-powered analysis, and an international reference view with dated market observations. Free forever. Cancel by closing the tab.
- Global Terminal access — tracked securities tracked across six regions, sortable, searchable, exportable. Explore the available market and company evidence together.
- CIN Take on published briefs and available company research — original editorial framing you won't find in press-release rewrites or aggregator feeds.
- The CMHI — our proprietary Cannabis Market Health Index, updated daily so you always know whether the sector tape is risk-on or defensive.
- One ticker bar, the whole sector — dated prices, market movers and volume where available, with account features through CIN.
- Daily Regional Briefs 10:00 UTC — six regional editions (US, Canada, Europe, APAC, Africa-Israel, LATAM) delivered every trading day. CIN-authored, sources cited, on your screen before the bell.
- The Sunday Capital Letter Sun · 6PM ET — our flagship weekly capital-markets recap: flows, regulatory shifts, the top 5 movers per region, and forward positioning for the week ahead. Read before Monday's open.
- Mid-day & Close Briefs — three editorial cadences per US trading day so you're never reading yesterday's tape.
- Macro Regime Read — where the sector sits in the CMHI and what's likely to drive the next leg, every Sunday.
- Ask anything, get sell-side-grade answers 10 queries/mo — pose any question on any ticker, any region, any sector trend and CIN's research engine answers with charts, primary sources, and editorial context in seconds.
- Charts & sources included — every answer cites the primary filing or disclosure it pulled from. No black box.
- Trained on the cannabis tape — not a general-purpose model retrofitted to the sector. Built specifically for cannabis equities, regulatory language, and capital structure.
- Personalized Watchlist + Smart Price & Catalyst Alerts — price moves, volume spikes, filings, and catalysts on the tickers you actually care about. Email or push, your call.
- Cannabis Catalyst Calendar — every earnings date, FDA/DEA milestone, state vote, and capital event with a 1–5 impact score so you know what actually matters.
- Portfolio Health Snapshot — performance vs MSOS, concentration risk, and CIN editorial risk notes on every holding. Know your exposure before the market does.
- Saved Screeners + Limited PDF Exports — build a screen once, export the results as a polished PDF and bring it into the next meeting.
- Insider & Filing Alerts — insider transactions, material events, prospectuses — surfaced the minute they hit the wire so you see them before the herd.
- Early access to new features — be first on the new tools, indices, and regional editions the moment they ship.
- Glossary & Methodology — every metric, index, and editorial choice documented and linkable. Show your work, always.
- Cross-device sync — watchlists, screeners, and alert preferences follow you from desk to phone, automatically.
"The cannabis equities tape moves on regulatory headlines, capital structure, and operator discipline — not on macro factors most analysts are trained to read. CIN is the only desk built to read it correctly."
Create your free account
No credit card. No trial. One step, and you're inside the terminal.
Is it really free?
Yes. The terminal, daily briefs, Sunday Capital Letter, watchlists, alerts, and 10 monthly Ask the Market queries are free forever. No card required, no trial countdown.
Who is CIN for?
Cannabis operators, allocators, retail investors, equity analysts, journalists, and policy professionals who want institutional-grade signal on the sector, without the Bloomberg-terminal price tag.
What if I need more queries?
Power users can upgrade to higher monthly limits and dedicated research pulls when paid tiers launch. Free accounts always keep the core terminal, briefs, and 10 monthly Ask the Market queries.
Read the Monday tape ahead of the room.
Join the cannabis investors who get CIN's brief in their inbox before the market opens — and the Sunday Capital Letter before they think about Monday.
Create Free Account — Takes 8 secondsCONTINUE YOUR RESEARCH